市場調査レポート
商品コード
1291630
インターベンショナルカーディオロジーおよび末梢血管装置の製品タイプ別市場(下大静脈(IVC)フィルター、プラーク修正装置、血行動態修正装置、付属品、血管形成術用バルーン、血管形成術用ステント、血管形成術用カテーテルInterventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
インターベンショナルカーディオロジーおよび末梢血管装置の製品タイプ別市場(下大静脈(IVC)フィルター、プラーク修正装置、血行動態修正装置、付属品、血管形成術用バルーン、血管形成術用ステント、血管形成術用カテーテル |
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界のインターベンショナルカーディオロジーおよび末梢血管装置の市場規模は、2022年に230億8,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に8.10%の成長率(CAGR)を示し、2028年までに382億8,000万米ドルに達すると予測しています。慢性的な心臓疾患に苦しむ人々の増加、末梢動脈疾患(PAD)の急増、低侵襲(MI)処置に対する消費者の嗜好の高まりが、市場を牽引する主要因の一部となっています。
インターベンショナルカーディオロジーとは、血管内カテーテルを用いた透視技術を駆使して、弁膜症、冠動脈、先天性心疾患などを治療する心臓病学のサブスペシャリティを指します。一方、末梢血管装置は、特に末梢血管系における動脈の閉塞や血管の狭窄を治療するために使用される医療機器であり、その結果、身体の様々な部位への血流が減少します。これらのインターベンションは、循環器系に影響を及ぼす心臓病や末梢血管障害を管理するために、合併症や傷跡を避け、痛みを最小限に抑え、より早い回復を促すために一般的に採用されている方法です。その結果、インターベンショナルカーディオロジーおよび末梢血管装置は、様々な構造的心臓疾患や動脈関連疾患の治療、および末梢血管内治療や冠動脈治療に幅広く応用されています。
冠動脈疾患(CAD)などの慢性的な心臓疾患を患う人の増加により、致命的な結果を防ぐための早期発見と介入の必要性が高まっています。これは、末梢動脈疾患(PAD)の発生率の上昇と相まって、市場の成長を促進する主な要因となっています。さらに、従来の手術から低侵襲(MI)手術への移行が、患者やヘルスケア関係者の間で進んでいます。MI手術は、切開面積が小さく、手術による痛み、傷、傷跡が少なく、入院期間が短く、精度が高く、回復が早いからです。また、高齢者人口の増加により、世界的に心臓・血管系疾患の負担が増加しており、製品需要が増加しています。さらに、急速な技術進歩により、主要メーカーは、より良い治療結果を得るために、インターベンショナルカーディオロジーおよび末梢血管装置の新しい革新的なバリエーションを開発しています。また、主要メーカーによる継続的な製品の発売や、製品認可の増加も、市場の成長を後押ししています。その他の要因としては、生体吸収性ステントのイントロダクション、救急・重症患者数の増加、有利な償還政策、ヘルスケアインフラの改善、継続的な研究開発活動などがあり、市場の成長を後押ししています。
本レポートに記載されている企業名は一部であり、全企業名は本レポートに記載されています。
The global interventional cardiology and peripheral vascular devices market size reached US$ 23.08 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.28 Billion by 2028, exhibiting a growth rate (CAGR) of 8.10% during 2023-2028. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.
Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts. These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.
The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery. In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes. Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global interventional cardiology and peripheral vascular devices market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, indication, age group, and end user.
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the product type. This includes inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts. According to the report, angioplasty balloons represented the largest segment.
A detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the indication has also been provided in the report. This includes coronary intervention and peripheral arterial disease.
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the age group. This includes geriatric, adults, and paediatric. According to the report, geriatric represented the largest segment.
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global interventional cardiology and peripheral vascular devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, Koninklijke Philips N.V., Medtronic plc., Teleflex Incorporated, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.